169 related articles for article (PubMed ID: 9863136)
21. Anticholinesterase effects of huperzine A, E2020, and tacrine in rats.
Wang H; Tang XC
Zhongguo Yao Li Xue Bao; 1998 Jan; 19(1):27-30. PubMed ID: 10375753
[TBL] [Abstract][Full Text] [Related]
22. Role of tyrosine 337 in the binding of huperzine A to the active site of human acetylcholinesterase.
Ashani Y; Grunwald J; Kronman C; Velan B; Shafferman A
Mol Pharmacol; 1994 Mar; 45(3):555-60. PubMed ID: 8145739
[TBL] [Abstract][Full Text] [Related]
23. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
[TBL] [Abstract][Full Text] [Related]
24. Anti-acetylcholinesterase activities of traditional Chinese medicine for treating Alzheimer's disease.
Lin HQ; Ho MT; Lau LS; Wong KK; Shaw PC; Wan DC
Chem Biol Interact; 2008 Sep; 175(1-3):352-4. PubMed ID: 18573242
[TBL] [Abstract][Full Text] [Related]
25. Effects of isovanihuperzine A on cholinesterase and scopolamine-induced memory impairment.
Xiong ZQ; Tang XC; Lin JL; Zhu DY
Zhongguo Yao Li Xue Bao; 1995 Jan; 16(1):21-5. PubMed ID: 7771190
[TBL] [Abstract][Full Text] [Related]
26. Acetylcholinesterase complexed with bivalent ligands related to huperzine a: experimental evidence for species-dependent protein-ligand complementarity.
Wong DM; Greenblatt HM; Dvir H; Carlier PR; Han YF; Pang YP; Silman I; Sussman JL
J Am Chem Soc; 2003 Jan; 125(2):363-73. PubMed ID: 12517147
[TBL] [Abstract][Full Text] [Related]
27. Five novel and highly efficient endophytic fungi isolated from Huperzia serrata expressing huperzine A for the treatment of Alzheimer's disease.
Wen-Xia H; Zhong-Wen H; Min J; Han Z; Wei-Ze L; Li-Bin Y; Fei L; Lu H; Ning Z; Xiao-Feng L
Appl Microbiol Biotechnol; 2020 Nov; 104(21):9159-9177. PubMed ID: 32970179
[TBL] [Abstract][Full Text] [Related]
28. Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students.
Sun QQ; Xu SS; Pan JL; Guo HM; Cao WQ
Zhongguo Yao Li Xue Bao; 1999 Jul; 20(7):601-3. PubMed ID: 10678121
[TBL] [Abstract][Full Text] [Related]
29. Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease.
Friedli MJ; Inestrosa NC
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770940
[TBL] [Abstract][Full Text] [Related]
30. New insights into huperzine A for the treatment of Alzheimer's disease.
Zhang HY
Acta Pharmacol Sin; 2012 Sep; 33(9):1170-5. PubMed ID: 22941287
[TBL] [Abstract][Full Text] [Related]
31. An overview on natural cholinesterase inhibitors--a multi-targeted drug class--and their mass production.
Orhan IE; Orhan G; Gurkas E
Mini Rev Med Chem; 2011 Sep; 11(10):836-42. PubMed ID: 21762104
[TBL] [Abstract][Full Text] [Related]
32. In vitro production of huperzine A, a promising drug candidate for Alzheimer's disease.
Ma X; Gang DR
Phytochemistry; 2008 Jul; 69(10):2022-8. PubMed ID: 18538805
[TBL] [Abstract][Full Text] [Related]
33. Non-cholinergic effects of huperzine A: beyond inhibition of acetylcholinesterase.
Zhang HY; Yan H; Tang XC
Cell Mol Neurobiol; 2008 Feb; 28(2):173-83. PubMed ID: 17657601
[TBL] [Abstract][Full Text] [Related]
34. The physicochemical properties and the in vivo AChE inhibition of two potential anti-Alzheimer agents, bis(12)-hupyridone and bis(7)-tacrine.
Yu H; Li WM; Kan KK; Ho JM; Carlier PR; Pang YP; Gu ZM; Zhong Z; Chan K; Wang YT; Han YF
J Pharm Biomed Anal; 2008 Jan; 46(1):75-81. PubMed ID: 17931815
[TBL] [Abstract][Full Text] [Related]
35. Huperzine a restores cortico-hippocampal functional connectivity after bilateral AMPA lesion of the nucleus basalis of meynert.
Rispoli V; Ragusa S; Nisticò R; Marra R; Russo E; Leo A; Felicitá V; Rotiroti D
J Alzheimers Dis; 2013; 35(4):833-46. PubMed ID: 23515019
[TBL] [Abstract][Full Text] [Related]
36. The new approach in development of anti-Alzheimer's disease drugs via the cholinergic hypothesis.
Sugimoto H
Chem Biol Interact; 2008 Sep; 175(1-3):204-8. PubMed ID: 18577377
[TBL] [Abstract][Full Text] [Related]
37. Improving effects of huperzine A on spatial working memory in aged monkeys and young adult monkeys with experimental cognitive impairment.
Ye JW; Cai JX; Wang LM; Tang XC
J Pharmacol Exp Ther; 1999 Feb; 288(2):814-9. PubMed ID: 9918593
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and docking studies of alkylene-linked dimers of (-)-huperzine A.
Jin G; Luo X; He X; Jiang H; Zhang H; Bai D
Arzneimittelforschung; 2003; 53(11):753-7. PubMed ID: 14677369
[TBL] [Abstract][Full Text] [Related]
39. Japanese Huperzia serrata extract and the constituent, huperzine A, ameliorate the scopolamine-induced cognitive impairment in mice.
Ohba T; Yoshino Y; Ishisaka M; Abe N; Tsuruma K; Shimazawa M; Oyama M; Tabira T; Hara H
Biosci Biotechnol Biochem; 2015; 79(11):1838-44. PubMed ID: 26059088
[TBL] [Abstract][Full Text] [Related]
40. Disease-Modifying Activity of Huperzine A on Alzheimer's Disease: Evidence from Preclinical Studies on Rodent Models.
Yan YP; Chen JY; Lu JH
Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499562
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
